Oxycodone/Naloxone

DRUG9 trials

Sponsors

Mundipharma Research GmbH & Co KG, Napp Pharmaceuticals Limited, Mundipharma Korea Ltd, Mundipharma (China) Pharmaceutical Co. Ltd, Fondazione IRCCS Policlinico San Matteo di Pavia

Conditions

Back PainCancerChronic PainConstipationEpidural AnalgesiaOral Oxycodone With/Without NaloxoneOsteoarthritisPain

Phase 2

A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain

CompletedNCT00513656

Mundipharma Research GmbH & Co KGCancer, Constipation, Pain

Start: 2007-09-30End: 2010-06-30Target: 230Updated: 2018-10-23

Phase 3

Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain

CompletedNCT01885182

Mundipharma (China) Pharmaceutical Co. LtdCancer, Pain

Start: 2013-06-01End: 2015-12-30Updated: 2019-10-04

Phase 4

A Study to Compare Oxycodone/Naloxone Prolonged Release Against Codeine/Paracetamol in the Treatment of Moderate to Severe Chronic Low Back Pain or Pain Due to Osteoarthritis

CompletedNCT00784810

Napp Pharmaceuticals LimitedBack Pain, Osteoarthritis

Start: 2009-02-28End: 2011-06-30Updated: 2011-11-02

A Study to Evaluate Efficacy and Safety of Oxycodone/Naloxone Compared to OxyContin in Korean Cancer Patients

CompletedNCT01313780

Mundipharma Korea LtdCancer

Start: 2011-05-31End: 2014-06-30Updated: 2017-12-22

PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain

CompletedNCT01719757

Mundipharma Korea LtdCancer

Start: 2012-07-31End: 2014-04-30Updated: 2016-08-19

An Interventional Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Spinal Disorders

CompletedNCT01811238

Mundipharma Korea LtdSpinal Disorders

Start: 2012-09-30End: 2013-07-31Updated: 2016-05-12

An Interventional Study to Compare the Efficacy and Tolerability With Targin® in Non-malignant Chronic Pain (GLORY)

CompletedNCT01811186

Mundipharma Korea LtdChronic Pain

Start: 2012-12-31End: 2014-06-30Updated: 2017-03-10

Treatment of Chronic Pain From Osteoarthritis

WithdrawnNCT02032927

Fondazione IRCCS Policlinico San Matteo di PaviaChronic Pain

Start: 2013-06-30End: 2015-06-30Updated: 2017-04-19

Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia

CompletedNCT02516059

Insel Gruppe AG, University Hospital BernEpidural Analgesia, Oral Oxycodone With/Without Naloxone, Postoperative Pain Management +2

Start: 2015-09-14End: 2017-02-28Updated: 2017-03-07

Related Papers

Analgesic Efficacy and Safety of Prolonged-Release Oxycodone/Naloxone in Korean Patients with Chronic Pain from Spinal Disorders

Clinics in Orthopedic Surgery2018-01-019 citations

Efficacy and safety of controlled-release oxycodone/naloxone versus controlled-release oxycodone in Korean patients with cancer-related pain: a randomized controlled trial.

2017-09-1110 citations

Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives.

2014-10-1315 citations